The first mechanism-based septic shock therapy!
Recently, Inotrem S.A. announced that the US Food and Drug Administration (FDA) has granted nangibotide (LR12) Fast Track designation (FTD) for the treatment of septic shock. Septic shock is the …
Recently, Inotrem S.A. announced that the US Food and Drug Administration (FDA) has granted nangibotide (LR12) Fast Track designation (FTD) for the treatment of septic shock. Septic shock is the …
Scientists are expected to develop a new type of cellular permeable peptide chimera to promote wound healing. In recent years, cell penetrating peptides as drug delivery carriers have aroused great …
Finally, Creative Peptides opens its first blog after the long-term preparation. With this blog, we are going to explore more with you in the field of bioactive peptides. Let’s get …